⚖️ Intellectual Property · Longevix™

Intellectual Property
& Copyright Notice

All Longevix™ content, methodologies, assessments, AI frameworks and proprietary systems are protected under Israeli and international intellectual property law.

Last updated: June 2026 · Effective: January 2025

©️ Copyright Notice

// Official Copyright Notice Copyright © 2025–2026 Longevix Ltd. All rights reserved. All content including but not limited to: protocols · assessments · research summaries · AI frameworks biomarker data · longevity methodologies · visual designs scoring systems · questionnaires · reports are protected by copyright and intellectual property laws.

כל תוכן Longevix — כולל פרוטוקולים, שאלונים, סיכומי מחקרים, מסגרות AI, מתודולוגיות, עיצובים ודוחות — מוגן בחוק זכויות יוצרים הישראלי ובאמנות בינלאומיות.

™ Proprietary Brands & Methodologies

סימני המסחר הבאים הם קניין קניין בלעדי של Longevix Ltd.:

Mark Description Status
LONGEVIX™Platform brand — AI-Powered Longevity IntelligencePending Registration
Vitality Score™Proprietary longevity scoring methodologyPending
Longevix AI Scientist™AI-powered longevity analysis systemPending
Longevix Protocol Engine™Personalized protocol generation frameworkPending
Longevix Biological Age™Proprietary biological age assessment methodologyPending
Longevix BioBuddy™AI health companion systemPending

™ denotes a proprietary mark. ® will be used upon successful trademark registration with the Israel Patent Office (ILPO).

🚫 Prohibited Uses

🚫 Strictly Prohibited — No Exceptions

  • AI Training: Automated extraction, scraping, crawling or reproduction of Longevix content for AI model training is strictly prohibited without prior written permission.
  • Commercial Reproduction: Copying, republishing or distributing Longevix protocols, assessments or research summaries for commercial purposes.
  • Scraping & Crawling: Automated data collection from longevix.co.il or longevix.global using bots, scrapers or crawlers beyond standard search engine indexing.
  • Derivative Works: Creating derivative products or services based substantially on Longevix methodologies, scoring systems or protocols without written license.
  • Brand Impersonation: Using Longevix™ marks, similar names or logos in a manner likely to cause confusion.
  • Unauthorized Translation: Translating and republishing Longevix content in any language without written permission.
# robots.txt — AI Training Prohibition User-agent: GPTBot Disallow: / User-agent: Google-Extended Disallow: / User-agent: CCBot Disallow: / User-agent: anthropic-ai Disallow: / User-agent: * Allow: / Disallow: /dashboard.html

✅ Permitted Uses

✅ Permitted Without Permission

  • Personal Use: Reading, saving and sharing Longevix content for personal, non-commercial health purposes.
  • Attribution Quotation: Quoting up to 50 words with clear attribution: "Source: Longevix.co.il" and a link to the original page.
  • Academic Reference: Citing Longevix as a source in academic work with proper attribution.
  • Search Engine Indexing: Standard search engine crawling for indexing purposes (Google, Bing, etc.).

📋 Permitted With Written License

  • Commercial redistribution of Longevix protocols or content
  • Integration of Longevix methodologies into third-party products
  • Translation and republication in other languages
  • Use of Longevix content in educational curricula

For licensing inquiries: legal@longevix.co.il

⚖️ Enforcement

Longevix Ltd. actively monitors for unauthorized use of its intellectual property. Violations may result in:

To report unauthorized use or request permission: legal@longevix.co.il

🇮🇱 Governing Law

This Intellectual Property Notice is governed by the laws of the State of Israel. Any disputes shall be subject to the exclusive jurisdiction of the courts of Tel Aviv-Yafo, Israel.

Longevix Ltd. is a company registered in Israel. All intellectual property rights are vested in Longevix Ltd.

Effective: January 2025 · Last Updated: June 2026 · Contact: legal@longevix.co.il